Targeting TREM2 with Small Molecule Agonists to Modulate Neuroinflammation in Alzheimer’s Disease

Time: 10:45 am
day: Day Two


• Highlighting TREM2 agonist ability to modulate inflammation in neurological indications

• Investigating TREM2 biology to identify the best stage of intervention

• Outlining model development and biomarker strategy to optimize translation into the clinic